.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

OMNISCAN Drug Profile

« Back to Dashboard
Omniscan is a drug marketed by Ge Healthcare and is included in two NDAs. It is available from one supplier.

The generic ingredient in OMNISCAN is gadodiamide. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the gadodiamide profile page.

Summary for Tradename: OMNISCAN

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list1

Pharmacology for Tradename: OMNISCAN

Clinical Trials for: OMNISCAN

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare
OMNISCAN
gadodiamide
INJECTABLE;INJECTION020123-001Jan 8, 1993RXYes<disabled><disabled>
Ge Healthcare
OMNISCAN
gadodiamide
INJECTABLE;INJECTION022066-001Sep 5, 2007DISCNNo<disabled><disabled>
Ge Healthcare
OMNISCAN
gadodiamide
INJECTABLE;INJECTION022066-002Sep 5, 2007RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: OMNISCAN

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ge Healthcare
OMNISCAN
gadodiamide
INJECTABLE;INJECTION022066-001Sep 5, 20075,560,903<disabled>
Ge Healthcare
OMNISCAN
gadodiamide
INJECTABLE;INJECTION020123-001Jan 8, 19934,687,659<disabled>
Ge Healthcare
OMNISCAN
gadodiamide
INJECTABLE;INJECTION020123-001Jan 8, 19935,560,903<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc